Expression of diagnostic neuronal markers and outcome in glioblastoma

Neuropathology and Applied Neurobiology

Volumn 36, Issue 5, 2010, Pages 411-421

  Donev, K ^a   Scheithauer, B W ^a   Rodriguez, F J ^a   Jenkins, S ^a  

^a MAYO CLINIC   (United States)

Author keywords

expression; giant cell glioblastoma; glioblastoma; neuronal markers; survival

Indexed keywords

CELL NUCLEUS ANTIGEN; CHROMOGRANIN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; NEURONAL NUCLEAR ANTIGEN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; NERVE PROTEIN; NEURONAL NUCLEAR ANTIGEN NEUN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; ELECTRON MICROSCOPY; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; SURVIVAL TIME; TUMOR VOLUME; ASTROCYTOMA; BRAIN TUMOR; GLIOMA; METABOLISM; MIDDLE AGED; MORTALITY; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHROMOGRANINS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77954477104     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2010.01078.x     Document Type: Article

References (24)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumors of the Central Nervous System.
2. Bodey B, Cosgrove M, Gonzalez-Gomez I, Siegel SE, Martin SE, Gilles FH. Co-expression of four intermediate filament subclasses in childhood glial neoplasms. Mod Pathol 1991 4 : 742 749
3. Cosgrove M, Fitzgibbons PL, Sherrod A, Chandrasoma PT, Martin SE. Intermediate filament expression in astrocytic neoplasms. Am J Surg Pathol 1989 13 : 141 145
4. Franke FE, Schachenmayr W, Osborn M, Altmannsberger M. Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors. Am J Pathol 1991 139 : 67 79
5. Hirato J, Nakazato Y, Ogawa A. Expression of non-glial intermediate filament proteins in gliomas. Clin Neuropathol 1994 13 : 1 11
6. Katsetos CD, Del Valle L, Geddes JF, Assimakopoulou M, Legido A, Boyd JC, Balin B, Parikh NA, Maraziotis T, de Chadarevian JP, Varakis JN, Matsas R, Spano A, Frankfurter A, Herman MM, Khalili K. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas. Arch Pathol Lab Med 2001 125 : 613 624
7. Martinez-Diaz H, Kleinschmidt-DeMasters BK, Powell SZ, Yachnis AT. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch Pathol Lab Med 2003 127 : 1187 1191
8. Shibahara J, Fukayama M. Secondary glioblastoma with advanced neuronal immunophenotype. Virchows Arch 2005 447 : 665 668
9. Varlet P, Soni D, Miquel C, Roux FX, Meder JF, Chneiweiss H, Daumas-Duport C. New variants of malignant glioneuronal tumors: a clinicopathological study of 40 cases. Neurosurgery 2004 55 : 1377 1391 : discussion 91-2
10. Wharton SB, Chan KK, Whittle IR. Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas. J Clin Neurosci 2002 9 : 165 169
11. Wharton SB, Lammie GA, Collie DA, Whittle IR. The significance of intratumoural neurones and neuronal differentiation in diffuse gliomas: a case series. Acta Neuropathologica 2000 100 : 695 700
12. Perry A, Scheithauer BW, Macaulay RJ, Raffel C, Roth KA, Kros JM. Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol 2002 61 : 947 955
13. Vyberg M, Ulhoi BP, Teglbjaerg PS. Neuronal features of oligodendrogliomas-an ultrastructural and immunohistochemical study. Histopathology 2007 50 : 887 896
14. Powell SZ, Yachnis AT, Rorke LB, Rojiani AM, Eskin TA. Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors. Am J Surg Pathol 1996 20 : 80 5
15. Giannini C, Scheithauer BW, Lopes MB, Hirose T, Kros JM, VandenBerg SR. Immunophenotype of pleomorphic xanthoastrocytoma. Am J Surg Pathol 2002 26 : 479 485
16. Lopes MB, Altermatt HJ, Scheithauer BW, Shepherd CW, VandenBerg SR. Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathologica 1996 91 : 368 375
17. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006 9 : 157 173
18. Gould VE, Lee I, Wiedenmann B, Moll R, Chejfec G, Franke WW. Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasms. Human Pathol 1986 17 : 979 983 (Pubitemid 17180631)
19. Perry A, Miller CR, Gujrati M, Scheithauer BW, Zambrano SC, Jost SC, Raghavan R, Qian J, Cochran EJ, Huse JT, Holland EC, Burger PC, Rosenblum MK. Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases. Brain Pathol 2009 19 : 81 90
20. Rodriguez FJ, Scheithauer BW, Robbins PD, Burger PC, Hessler RB, Perry A, Abell-Aleff PC, Mierau GW. Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum. Acta Neuropathologica 2007 113 : 313 324
21. Martinez R, Roggendorf W, Baretton G, Klein R, Toedt G, Lichter P, Schackert G, Joos S. Cytogenetic and molecular genetic analyses of giant cell glioblastoma multiforme reveal distinct profiles in giant cell and non-giant cell subpopulations. Cancer Genet Cytogenet 2007 175 : 26 34
22. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002 39 : 193 206
23. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF. Gene expression profiling of gliomas strongly predicts survival. Cancer Res 2004 64 : 6503 6510
24. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003 63 : 1602 1607